首页> 外文期刊>Technology in cancer research & treatment. >Experimental Validation of Monte Carlo Simulations Based on a Virtual Source Model for TomoTherapy in a RANDO Phantom
【24h】

Experimental Validation of Monte Carlo Simulations Based on a Virtual Source Model for TomoTherapy in a RANDO Phantom

机译:基于虚拟源模型的RANDO幻影TomoTherapy的Monte Carlo模拟的实验验证

获取原文
获取原文并翻译 | 示例
           

摘要

A virtual source model for Monte Carlo simulations of helical TomoTherapy has been developed previously by the authors. The purpose of this work is to perform experiments in an anthropomorphic (RANDO) phantom with the same order of complexity as in clinical treatments to validate the virtual source model to be used for quality assurance secondary check on TomoTherapy patient planning dose. Helical TomoTherapy involves complex delivery pattern with irregular beam apertures and couch movement during irradiation. Monte Carlo simulation, as the most accurate dose algorithm, is desirable in radiation dosimetry. Current Monte Carlo simulations for helical TomoTherapy adopt the full Monte Carlo model, which includes detailed modeling of individual machine component, and thus, large phase space files are required at different scoring planes. As an alternative approach, we developed a virtual source model without using the large phase space files for the patient dose calculations previously. In this work, we apply the simulation system to recompute the patient doses, which were generated by the treatment planning system in an anthropomorphic phantom to mimic the real patient treatments. We performed thermoluminescence dosimeter point dose and film measurements to compare with Monte Carlo results. Thermoluminescence dosimeter measurements show that the relative difference in both Monte Carlo and treatment planning system is within 3%, with the largest difference less than 5% for both the test plans. The film measurements demonstrated 85.7% and 98.4% passing rate using the 3 mm/3% acceptance criterion for the head and neck and lung cases, respectively. Over 95% passing rate is achieved if 4 mm/4% criterion is applied. For the dose-volume histograms, very good agreement is obtained between the Monte Carlo and treatment planning system method for both cases. The experimental results demonstrate that the virtual source model Monte Carlo system can be a viable option for the accurate dose calculation of helical TomoTherapy.
机译:作者先前已经开发了用于螺旋TomoTherapy的蒙特卡罗模拟的虚拟源模型。这项工作的目的是在拟人化(RANDO)人体模型中进行实验,其复杂度与临床治疗中的顺序相同,以验证用于对TomoTherapy患者计划剂量进行质量保证二次检查的虚拟源模型。螺旋型TomoTherapy疗法涉及复杂的输送方式,其束孔不规则,并且在照射过程中会发生床移动。作为最精确的剂量算法,蒙特卡罗模拟是放射线剂量测定中所需要的。当前的螺旋TomoTherapy蒙特卡罗模拟采用完整的蒙特卡洛模型,其中包括对单个机器组件的详细建模,因此,在不同的计分平面上需要较大的相空间文件。作为一种替代方法,我们开发了一个虚拟源模型,而以前没有使用较大的相空间文件来计算患者剂量。在这项工作中,我们将模拟系统应用于重新计算患者剂量,这些剂量是由治疗计划系统在拟人模型中生成的,用以模拟实际的患者治疗。我们进行了热致发光剂量计点剂量和薄膜测量,以与蒙特卡洛结果进行比较。热致发光剂量计测量结果表明,蒙特卡洛和治疗计划系统的相对差异在3%以内,两个测试计划的最大差异均小于5%。膜测量结果表明,对于头颈部和肺部病例,使用3 mm / 3%的接受标准,合格率分别为85.7%和98.4%。如果采用4 mm / 4%的标准,则可以达到95%以上的通过率。对于剂量-体积直方图,在这两种情况下,蒙特卡罗方法和治疗计划系统方法之间都获得了很好的一致性。实验结果表明,虚拟源模型蒙特卡洛系统可以作为螺旋TomoTherapy精确剂量计算的可行选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号